VitalConnect

15 articles about VitalConnect

• VitalConnect Announces Investment from HCA Healthcare to Accelerate Commercial Growth and Create Strategic Partnership

  9/12/2022

  VitalConnect®, Inc. announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., one of the nation’s leading healthcare providers.

• VitalConnect Announces Closure of $39 Million Round of Growth Financing

  1/10/2022

  Series E Financing led by EW Healthcare Partners with Robert S. White to Join Board.

• VitalConnect Wirelessly Monitors COVID-19 Patients at Northwell Plainview Hospital

  5/5/2021

  Vista Solution from VitalConnect being used at New York facility to monitor vitals and customize solutions to patient needs

• VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study

  9/16/2020

  Study will evaluate the impact of remote patient monitoring on clinical outcomes, readmission rates, and patient satisfaction following a transcatheter aortic valve replacement procedure

• FDA Grants Emergency Use Authorization to VitalConnect for Cardiac Monitoring in COVID-19 Patients

  5/5/2020

  VitalConnect ® , Inc. , a leader in wearable biosensor technology, announced it was granted Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA

• VitalConnect Announces Launch of Arrhythmia Detection for Cardiac Patient Care

  2/12/2020

  Arrhythmia detection to further expand monitoring options in cardiology community

• VitalConnect Announces Peter Van Haur as Chief Executive Officer

  7/15/2019

  VitalConnect, Inc., a leader in wearable biosensor technology for wireless monitoring in hospital and remote patient populations, today announced the appointment of Peter Van Haur as chief executive officer (CEO), effective immediately.

• VitalConnect Unveils Vista Solution 2.0 to Improve Real-time Patient Monitoring for Earlier Intervention

  2/12/2019

  New analytics will improve the detection and response to patients in hospitals and at home

• VitalConnect Launches VistaTablet to Further Focus on Growing At-Home Patient Monitoring Space

  8/15/2018

  Company brings FDA cleared, clinical-grade and continuous monitoring to patients' homes

• Netherlands-based Haga Teaching Hospital partners with physIQ and VitalConnect to continuously monitor cancer patients during treatment

  7/10/2018

  Cancer patients are equipped with wearable biosensors for monitoring before, during and after cancer treatment

• VitalConnect Announces Joe Lynch as Chief Marketing Officer

  5/24/2018

  VitalConnect®, Inc., a leader in wearable biosensor technology for wireless monitoring in hospital and remote patient populations, today announced the addition of chief marketing officer Joe Lynch.

• 

  VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device

  12/7/2017

  This clearance extends the wear duration for the company's existing Class 2 wearable biosensor, the VitalPatch, by 25 percent from 96 hours to 120 hours.

• Oxford Finance Provides $20M Senior Debt Facility to VitalConnect

  11/29/2017

  The funds are being used to further the commercialization of the VitalConnect solution suite for both hospital and remote patient monitoring markets.

• 

  Bay Area's VitalConnect Banks $38M Series C

  10/31/2017

  The round was led by MVM and Baxter Ventures.

• Bay Area's VitalConnect Snags $33 Million Series C

  5/23/2017